Polaryx Therapeutics, Inc. PLYX Share-Based Payment - Nonvested Awards (Number)
Share-Based Payment - Nonvested Awards (Number) at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.
The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Polaryx Therapeutics, Inc. 's share-based payment - nonvested awards (number).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Polaryx Therapeutics, Inc. 's share-based payment - nonvested awards (number)?
- Polaryx Therapeutics, Inc. (PLYX) reported share-based payment - nonvested awards (number) of $4.19M in Q4 2025.
- What is the long-term trend for Polaryx Therapeutics, Inc. 's share-based payment - nonvested awards (number)?
- Over 2 years (2023 to 2025), Polaryx Therapeutics, Inc. 's share-based payment - nonvested awards (number) has grown at a 109.3% compound annual growth rate (CAGR), from $955.95K to $4.19M.
- What does share-based payment - nonvested awards (number) mean?
- This metric tracks the total number of outstanding equity awards, such as restricted stock units or performance shares, that have been granted to employees but have not yet vested. It represents potential future dilution for existing shareholders as these awards convert into common stock over time. Monitoring this helps investors understand the company's long-term incentive structure and potential equity overhang.